|
Patient reported being injected with an unspecified juvéderm®.The next year, the patient experienced ¿bumps¿ all over the face, under the lips, and sides of the cheeks¿ that were described as ¿pretty thick¿ on the upper lip, some on the jawline, and on the cheekbone, the size of ¿maybe a dime or nickel.¿ a ct scan confirmed the nodules.The patient as treated with amoxicillin that they had just completed, and steroids were considered next.The filler looked like it was ¿protruding out the sides of the face.¿ event was ongoing.Additionally, the healthcare professional reported that the patient was injected in the cheek, lips, and jawline with 1 cc of juvéderm® voluma¿ xc, 1 cc of juvéderm® volbella¿ xc, and 1 cc of juvéderm® volux¿ xc.The event occurred at the injection sites.The amoxicillin treatment was not given by the injector, and no specifics could be given for it.Two months post-onset, the patient was treated with keflex 500 mg po bid.Two weeks later, the patient was treated with a medrol dosepak to be taken as directed and hylenex.This file captured the juvéderm® volbella¿ xc.
|
|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been completed.No deviations or non-conformances noted.This is a known potential adverse event addressed in the product labeling.This report was impacted by emdr scheduled maintenance occurring (b)(6) 2026.
|